(Q43771587)

26 November 2017

Is continued enthusiasm for ursodeoxycholic acid therapy for the treatment of primary biliary cirrhosis warranted? (English)

1 reference

primary biliary cholangitis

26 November 2017

0 references

author name string

R. H. Wiesner

series ordinal

1

1 reference

PubMed ID

1568740

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1568740

9 October 2022

language of work or name

English

0 references

publication date

1 May 1992

1 reference

26 November 2017

1 reference

26 November 2017

15

1 reference

26 November 2017

5

1 reference

26 November 2017

971-973

1 reference

Clinical and statistical analyses of new and evolving therapies for primary biliary cirrhosis

26 November 2017

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150536

7 January 2021

A controlled trial of cyclosporine in the treatment of primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150536

7 January 2021

A prospective trial of colchicine for primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150536

7 January 2021

Medical treatment of primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150536

7 January 2021

Even the French foie gras de canard does not induce portal hypertension

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150536

7 January 2021

Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis)

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150536

7 January 2021

Identifiers

DOI

10.1002/HEP.1840150536

1 reference

26 November 2017

1 reference

PubMed ID

1568740